Compare WEST & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEST | TOI |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Nursing Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.6M | 444.1M |
| IPO Year | N/A | N/A |
| Metric | WEST | TOI |
|---|---|---|
| Price | $4.33 | $2.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $9.00 | $6.00 |
| AVG Volume (30 Days) | 625.7K | ★ 3.1M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,078,457,000.00 | $461,039,000.00 |
| Revenue This Year | $40.23 | $21.71 |
| Revenue Next Year | $8.80 | $20.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 28.89 | 21.67 |
| 52 Week Low | $3.59 | $0.15 |
| 52 Week High | $8.29 | $4.88 |
| Indicator | WEST | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 36.30 |
| Support Level | $4.00 | $2.88 |
| Resistance Level | $4.48 | $3.20 |
| Average True Range (ATR) | 0.29 | 0.34 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 57.74 | 5.77 |
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.